By analyzing the data from the TCGA database, we demonstrated that upregulated expression of VCIP135 and MAT2A is also associated with poor prognosis of HCC patients, which is consistent with our current findings that MATIIα-integrated folate metabolism and methionine cycle promotes HCC development (Fig. 6k). This evidence concerns the gene MAT2A and hepatocellular carcinoma.